EFFICACY AND SAFETY OF CABERGOLINE AS A FIRST-LINE TREATMENT FOR INVASIVE GIANT MALE PROLACTINOMA

被引：0
|
作者：
Kim, Jeong Hoon [1 ]
Kim, Chang Jin [1 ]
Cho, Eun Hee [2 ]
Kim, Min-Seon [2 ]
机构：
[1] Univ Ulsan, Coll Med, Dept Neurol Surg, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Div Endocrinol & Metab, Dept Internal Med,Asan Med Ctr, Seoul, South Korea
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：941 / 941
页数：1
相关论文
共 50 条
  • [11] Clozapine Treatment for Cabergoline-Induced Psychosis in a Patient With a Giant Prolactinoma
    Perez-Esparza, Rodrigo
    Alberto Rojas-Guerrero, Carlos
    Geovany Andino-Rios, Gerson
    Arias-Garro, Patricia
    Ramirez-Bermudez, Jesus
    Portocarrero-Ortiz, Lesly
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2017, 29 (03) : 295 - 297
  • [12] The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review
    Chen, Yan
    Zhao, Jiaojiao
    Wang, Yifei
    Ge, Long
    Kwong, Joey Sum-wing
    Lan, Junjie
    Zhang, Rui
    Zhao, Huaye
    Hu, Linfang
    Wang, Jiaxue
    Sun, Shuimei
    Tan, Songsong
    Lin, Xiaoqing
    He, Rui
    Zheng, Wenyi
    Li, Xiaosi
    Zhang, Jiaxing
    FRONTIERS IN PHARMACOLOGY, 2025, 15
  • [13] Caspofungin: first-line treatment of invasive candidiasis
    Reynes, J
    JOURNAL DE MYCOLOGIE MEDICALE, 2004, 14 (04): : 235 - 239
  • [14] Brigatinib in the first-line treatment of ALK plus metastatic NSCLC: safety and efficacy
    Bronte, Giuseppe
    Cafaro, Alessandro
    Pasini, Luigi
    Priano, Ilaria
    Andrikou, Kalliopi
    Cravero, Paola
    Burgio, Marco Angelo
    Delmonte, Angelo
    Crino, Lucio
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) : 809 - 817
  • [15] Determining first-line CLL/SLL treatment strategies with optimized efficacy and safety
    Mehta, Amitkumar
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (SUPPL 2) : S14 - S19
  • [16] Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States
    Haan, Bradley J.
    Cadiz, Megan L.
    Natavio, Allycia M.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (03) : 213 - 218
  • [17] BEVACIZUMAB IN COMBINATION WITH IRINOTECANAND CAPECITABINE AS FIRST-LINE TREATMENT FOR MCRC - EFFICACY AND SAFETY
    Sasa, Jungic
    Gordana, Kecman Malcic
    Ivanka, Rakita
    Dusan, Jovanovic
    Radoslav, Gajanin
    Zdravko, Maric
    Biljana, Tubic
    Zdenka, Gojkovic
    ANNALS OF ONCOLOGY, 2014, 25
  • [18] Giant prolactinomas in men: efficacy of cabergoline treatment
    Corsello, SM
    Ubertini, G
    Altomare, M
    Lovicu, RM
    Migneco, MG
    Rota, CA
    Colosimo, C
    CLINICAL ENDOCRINOLOGY, 2003, 58 (05) : 662 - 670
  • [19] Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report
    Castro-Castro, J.
    Torre-Eiriz, J. A.
    Pinzon-Millan, A.
    Pastor-Zapata, A.
    NEUROCIRUGIA, 2011, 22 (06): : 558 - 561
  • [20] Efficacy and safety of rituximab as first-line therapy in NMOSD compared with other first-line immunosuppressive treatments
    Pouparti, J.
    Giovanelli, J.
    Deschamps, R.
    Durand-Dubief, F.
    Audoin, B.
    Ciron, J.
    Maillart, E.
    Papeix, C.
    Collongues, N.
    Bourre, B.
    Cohen, M.
    Wiertlewski, S.
    Laplaud, D.
    Brassat, D.
    Vukusic, S.
    Marignier, R.
    Zephir, H.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 474 - 475
12345